Discovery

Systematic, data-driven science coverage · Wednesday, July 29, 2026
The AllSci BriefSystematic R&D and deal news. Daily.
Most Read
Business

Caldera taps reverse merger to advance TL1A × IL-23 bispecific

Caldera taps reverse merger to advance TL1A × IL-23 bispecific
Business

Adjuvia raises USD 8m for preclinical-stage mitochondrial therapy

Adjuvia raises USD 8m for preclinical-stage mitochondrial therapy
Business

AbCellera adds Vertex as latest TCE platform partner in autoimmune disease

AbCellera adds Vertex as latest TCE platform partner in autoimmune disease
Business

Qnovia bets on antimicrobial peptides with exclusive UVA deal

Qnovia bets on antimicrobial peptides with exclusive UVA deal
Business

LB Pharma raises USD 150m to expand LB-102 zinto three neuropsychiatric indications

LB Pharma raises USD 150m to expand LB-102 zinto three neuropsychiatric indications
More from Discovery
Einstein College of Medicine receives USD 13.8m NIAID grant for rapid-response viral vaccine platform
Discovery

Einstein College of Medicine receives USD 13.8m NIAID grant for rapid-response viral vaccine platform

Albert Einstein College of Medicine has received a USD 13.8 million NIAID U19 cooperative agreement to lead PROVIDENT, a 13-institution consortium...

2d agoFeinstein Institutes releases comprehensive vagus nerve atlas from 30 donors, advancing bioelectronic medicine device design
Discovery

Feinstein Institutes releases comprehensive vagus nerve atlas from 30 donors, advancing bioelectronic medicine device design

Researchers at the Feinstein Institutes for Medical Research, the research arm of Northwell Health in Manhasset, New York, have released the most detailed...

2d agoNIH backs MD Anderson with USD 3m grant to validate tumor prediction NAMs in CRC trials
Discovery

NIH backs MD Anderson with USD 3m grant to validate tumor prediction NAMs in CRC trials

The University of Texas MD Anderson Cancer Center has received a USD 3 million NIH cooperative agreement to validate predictive tumor models — combining in...

2d agoIsoprene advances AR-V7-targeting molecular glue degrader with NCI funding
Discovery

Isoprene advances AR-V7-targeting molecular glue degrader with NCI funding

Baltimore-based Isoprene Pharmaceuticals, Inc. has received a USD 1.02 million NCI SBIR R44 grant to complete IND-enabling preclinical studies for...

2d agoNIH backs Mount Sinai's FSH-blocking antibody for Down syndrome Alzheimer's
Discovery

NIH backs Mount Sinai's FSH-blocking antibody for Down syndrome Alzheimer's

Icahn School of Medicine at Mount Sinai has received a USD 1,210,250 NIH R01 grant to test whether blocking follicle-stimulating hormone (FSH) can reduce...

5d agoPhoenix Nest gets NIH backing for Sanfilippo syndrome gene therapy manufacturing
Discovery

Phoenix Nest gets NIH backing for Sanfilippo syndrome gene therapy manufacturing

Phoenix Nest, a Brooklyn, New York-based biotechnology company, has received a USD 1.49 million NIH SBIR grant to fund manufacturing and analytical...

5d agoMichigan secures NIH funding to advance ASO therapy for CLN3 Batten disease
Discovery

Michigan secures NIH funding to advance ASO therapy for CLN3 Batten disease

The University of Michigan at Ann Arbor has received a USD 1.35 million NIH U01 grant to conduct IND-enabling studies for an antisense oligonucleotide (ASO)...

Jul 22Cambium secures NCI funding to advance VIP checkpoint therapy for AML
Discovery

Cambium secures NCI funding to advance VIP checkpoint therapy for AML

Cambium Oncology LLC, an Atlanta-based biotech, has received a USD 1.05 million SBIR fast-track grant from the National Cancer Institute to advance...

Jul 22
The AllSci BriefSystematic R&D and deal news. Daily.
NIH backs overdose-limiting oxycodone prodrug with USD 5.28m award
Discovery

NIH backs overdose-limiting oxycodone prodrug with USD 5.28m award

Ensysce Biosciences (La Jolla, California) has received a USD 5.28 million U01 cooperative agreement from the National Institute on Drug Abuse to continue...

Jul 22Jacaranda takes SBIR Phase II grant for noise-induced hearing loss therapeutics
Discovery

Jacaranda takes SBIR Phase II grant for noise-induced hearing loss therapeutics

Jacaranda Bioscience, Inc., a San Francisco-based biotech, has received a USD 1.44 million SBIR Phase II award from the National Institute on Deafness and...

Jul 22Curatix secures NIAID support for drug-resistant fungal infection adjuvants
Discovery

Curatix secures NIAID support for drug-resistant fungal infection adjuvants

The Small Business Innovation Research (SBIR) mechanism at the National Institute of Allergy and Infectious Diseases (NIAID) has awarded a USD 1.0 million...

Jul 21Merakris picks up NIH grant to support MTX-001 into diabetic foot ulcer trials
Discovery

Merakris picks up NIH grant to support MTX-001 into diabetic foot ulcer trials

Merakris Therapeutics, a Research Triangle Park, North Carolina-based clinical-stage biotechnology company, has received a Direct-to-Phase II Small Business...

Jul 21EpiCure Therapeutics secures NIH grant for SLC6A1 gene therapy development
Discovery

EpiCure Therapeutics secures NIH grant for SLC6A1 gene therapy development

EpiCure Therapeutics, Inc., a Seattle, Washington-based Allen Institute spinout, has received a USD 1.5 million NIH R44 grant to advance an AAV gene therapy...

Jul 20MSK developing machine learning models to map gene networks in RA
Discovery

MSK developing machine learning models to map gene networks in RA

Memorial Sloan-Kettering Cancer Center has received a USD 1.12 million NIH supplemental award to build machine learning models of gene regulatory networks...

Jul 17MD Anderson investigates Bhlhe40’s role in T cell function during immunotherapy
Discovery

MD Anderson investigates Bhlhe40’s role in T cell function during immunotherapy

The University of Texas MD Anderson Cancer Center has received a USD 1.82 million National Cancer Institute R01 renewal to investigate how the transcription...

Jul 17